Dermapharm Holding SE (CHIX:DMPD) Cash per Share: €5.13 (As of Mar. 2026)

What is Dermapharm Holding SE Cash per Share?

Dermapharm Holding SE CHIX:DMPD 80 Cash per Share is €5.13 as of Mar. 2026. GuruFocus rates CHIX:DMPD with a GF Score™ of 80/100 and a GF Value™ of €39.87. The stock has 10 warning signs investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Dermapharm Holding SE's Cash per Share for the quarter that ended in Mar. 2026 was €5.13.

Dermapharm Holding SE (CHIX:DMPd) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Dermapharm Holding SE Cash per Share Related Terms

Dermapharm Holding SE Cash per Share Historical Data

* Premium members only.

The historical data trend for Dermapharm Holding SE's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dermapharm Holding SE Cash per Share Chart

Dermapharm Holding SE Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Cash per Share

Get a 7-Day Free Trial

3.20

3.00

2.96

2.26

3.79

Dermapharm Holding SE Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Cash per Share	Get a 7-Day Free Trial															2.19	3.08	2.79	3.79	5.13

80GF Score

Dermapharm Holding SE CHIX:DMPD

Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Dermapharm Holding SE Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Dermapharm Holding SE's Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	204.147	/	54
	=	3.79

Dermapharm Holding SE's Cash per Share for the quarter that ended in Mar. 2026 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	253.995	/	50
	=	5.13

Frequently Asked Questions Learn more about Cash per Share →

What does a Cash per Share of €5.13 mean?

Dermapharm Holding SE (CHIX:DMPD) has a Cash per Share of €5.13 as of Mar. 2026. Cash per share is the per-share value of a company's available cash. View historical data for Dermapharm Holding SE and its competitors.

Is Dermapharm Holding SE's Cash per Share too high?

Dermapharm Holding SE's current Cash per Share is €5.13. Overall, Dermapharm Holding SE has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.

How does Dermapharm Holding SE's Cash per Share compare to ZTS and UTHR?

Dermapharm Holding SE's Cash per Share of €5.13 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Cash per Share for a Drug Manufacturers company?

A good Cash per Share depends on the Drug Manufacturers industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Cash per Share mean?

A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for Dermapharm Holding SE and its competitors. Dermapharm Holding SE's current Cash per Share is €5.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Dermapharm Holding SE stock overvalued right now?

Dermapharm Holding SE (CHIX:DMPD) has a current Cash per Share of €5.13. The stock's GF Value™ is €39.87, compared to a current price of €46.18 — trading 15.8% above its estimated fair value. The current Cash per Share is €5.13. Dermapharm Holding SE's overall GF Score™ is 80/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Cash per Share calculated?

Cash per Share is calculated from a company's financial statements. For Dermapharm Holding SE (CHIX:DMPD), the current Cash per Share is €5.13 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dermapharm Holding SE (CHIX:DMPD) Overvalued in 2026?

Based on GuruFocus' analysis, Dermapharm Holding SE stock appears to be overvalued. The current stock price of €46.18 is trading 15.8% above its estimated GF Value™ of €39.87.

Key valuation signals for CHIX:DMPD:

Cash per Share: €5.13
GF Value™: €39.87 vs. price of €46.18 (15.8% above fair value)
GF Score™: 80/100 with 10 warning signs

No single metric tells the full story. See the CHIX:DMPD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dermapharm Holding SE Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies XTER:EVT XTER:B8FK XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR HKSE:03692 VTRS NSE:DIVISLAB OSTO:SOBI NBIX NSE:TORNTPHARM SHSE:688506 XPAR:IPN

Other Exchanges DMPHF:USA 0A5J:UK DMP:Germany

Address Lil-Dagover-Ring 7, Grunwald, BY, DEU, 82031

Website https://www.dermapharm.com

Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals, which drive key revenue, Other healthcare products, and Parallel import business. The Branded pharmaceuticals segment covers numerous product areas through a wide variety of items sold under reputable brand names.

80GF Score

Get the complete analysis for CHIX:DMPD

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€46.18

Price

€39.87

GF Value

View CHIX:DMPD Analysis

See Cash per Share data for all stocks →